Abstract:The therapeutic precision and clinical applicability of drug-eluting coatings can be substantially improved by facilitating tunable drug delivery. However, the design of coatings which allows for precise control over drug release kinetics is still a major challenge. Here, a double-layered silk fibroin (SF) coating system was constructed by sequential electrophoretic deposition. A mixture of dissolved Bombyx mori SF (bmSF) molecules and pre-made bmSF nanospheres at different ratios was deposited as under-layer. Subsequently, this underlayer was covered by a top-layer comprising Antheraea pernyi SF (apSF) molecules (rich in arginylglycylaspartic acid, RGD) to improve the cellular response of the resulting double-layered coatings. Additionally, model drug doxycycline was either pre-mixed with dissolved bmSF molecules or pre-loaded into pre-made bmSF nanospheres at the same amount before their mixing and deposition. The thickness and nanosphere content of the under-layer architecture were proportional to the deposition time and nanosphere concentration in precursor mixtures, respectively. The surface topography, wettability, degradation rate and adhesion strength were comparable within the double-layered coating system. As expected, RGD-rich apSF top-layer improved cell adhesion, spreading and proliferation compared with bmSF top-layer. Furthermore, the amount and duration of drug release increased linearly with increasing nanosphere concentration at fixed deposition time, whereas drug release amount increased linearly with increasing deposition time. These results indicate that the dosage and kinetics of loaded drugs can be quantitatively tailored by altering nanosphere concentration and deposition time as main processing parameters. Overall, this study illustrates the strong potential of pre-defining coating architecture to facilitate control over drug delivery.

Electrodeposited Assembly of Additive-Free Silk Fibroin Coating from Pre-Assembled Nanospheres for Drug Delivery

Development of Random and Ordered Composite Fiber Hybrid Technologies for Controlled Release Functions

A Novel Approach for Tailored Medicines: Direct Writing of Janus Fibers

Electrophoretic deposition of silk fibroin coatings with pre-defined architecture to facilitate precise control over drug delivery

Electrophoretic deposition of coatings for local delivery of therapeutic agents

Fabrication of Patterned Three-Dimensional Micron Scaled Core-Sheath Architectures for Drug Patches

Fabrication of silk fibroin nanoparticles for controlled drug delivery

Self-coated Interfacial Layer at Organic/inorganic Phase for Temporally Controlling Dual-Drug Delivery from Electrospun Fibers.

Electrospun Fibre Composite for Controlled Drug Release

Electrospun Poly (Ɛ-Caprolactone)/silk Fibroin Core-Sheath Nanofibers and Their Potential Applications in Tissue Engineering and Drug Release

Electrospun Polymeric Fibers Decorated with Silk Microcapsules Via Encapsulation and Surface Immobilization for Drug Delivery.

Silk Fibroin Assisted Cathodic Electrolytic Deposition of Calcium Phosphate for Biomedical Applications

Electrospun Fibers with Blank Surface and Inner Drug Gradient for Improving Sustained Release.

Preparation and Characterization of Electrospun PLGA-SF Nanofibers As a Potential Drug Delivery System

Accelerated Fabrication of Antibacterial and Osteoinductive Electrospun Fibrous Scaffolds Via Electrochemical Deposition

Multilayered drug delivery coatings composed of daidzein-loaded PHBV microspheres embedded in a biodegradable polymer matrix by electrophoretic deposition

Design and efficacy of all-in-one sandwich-like multifunctional platform for drug delivery

Preparation of 3,4-Dihydroxy-L-phenylalanine modified organic-inorganic hybrid coatings for drug eluting stents

Electrophoretic Deposition of Gelatine Nanoparticle/chitosan Coatings

Electrospun silk fibroin/polyethylene oxide composite scaffolds with strontium or copper-doped hollow bioactive glass nanospheres for pH-triggered sustained drug release

Electrosprayed Ultra-Thin Coating of Ethyl Cellulose on Drug Nanoparticles for Improved Sustained Release